NCT00354809 - Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Sleep Initiation and Maintenance DisordersInsomnia

Interventions

DRUG

GW679769

Trial Locations (24)

10117

GSK Investigational Site, Berlin

10559

GSK Investigational Site, Berlin

13125

GSK Investigational Site, Berlin

14050

GSK Investigational Site, Berlin

19053

GSK Investigational Site, Schwerin

28304

GSK Investigational Site, Fayetteville

30024

GSK Investigational Site, Suwanee

30214

GSK Investigational Site, Fayetteville

31313

GSK Investigational Site, Hinesville

33009

GSK Investigational Site, Hallandale

33137

GSK Investigational Site, Miami

34613

GSK Investigational Site, Schwalmstadt

37075

GSK Investigational Site, Göttingen

41017

GSK Investigational Site, Crestview Hills

68250

GSK Investigational Site, Rouffach

70115

GSK Investigational Site, New Orleans

70809

GSK Investigational Site, Baton Rouge

73103

GSK Investigational Site, Oklahoma City

75181

GSK Investigational Site, Paris

81675

GSK Investigational Site, Munich

85306

GSK Investigational Site, Glendale

91204

GSK Investigational Site, Glendale

92140

GSK Investigational Site, Clamart

02459

GSK Investigational Site, Newton